{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:53:03Z","timestamp":1791078783167,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.jbspin.2006.06.004","type":"journal-article","created":{"date-parts":[[2006,11,29]],"date-time":"2006-11-29T22:25:15Z","timestamp":1164839115000},"page":"39-47","source":"Crossref","is-referenced-by-count":68,"title":["Effects of osteoporosis medications on bone quality"],"prefix":"10.1016","volume":"74","author":[{"given":"Claude-Laurent","family":"Benhamou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2006.06.004_bib1","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures","volume":"312","author":"Marshall","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.jbspin.2006.06.004_bib2","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/oxfordjournals.aje.a115204","article-title":"Epidemiology of vertebral fractures in women","volume":"129","author":"Melton","year":"1989","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jbspin.2006.06.004_bib3","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1359\/JBMR.040134","article-title":"A meta-analysis of prior corticosteroid use and fracture risk","volume":"19","author":"Kanis","year":"2004","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jbspin.2006.06.004_bib4","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1359\/JBMR.041230","article-title":"Low skeletal muscle mass is associated with poor structural parameters of bone and impaired balance in elderly men. The Minos Study","volume":"20","author":"Szulc","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2006.06.004_bib5","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/0002-9343(93)90218-E","article-title":"Prophylaxis and treatment of osteoporosis","volume":"94","author":"Consensus Development conference","year":"1993","journal-title":"Am J Med"},{"key":"10.1016\/j.jbspin.2006.06.004_bib6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","volume":"285","author":"NIH Consensus Development Panel in osteoporosis prevention, diagnosis, and therapy","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2006.06.004_bib7","series-title":"Les osteoporoses","author":"GRIO (C.L. Benhamou coord.)","year":"2005"},{"key":"10.1016\/j.jbspin.2006.06.004_bib8","series-title":"Les d\u00e9terminants multi \u00e9chelle de la fragilit\u00e9 osseuse\u2014Comit\u00e9 d'Interface Inserm\u2014Appareil","author":"C.L. Benhamou, coord.","year":"2005"},{"key":"10.1016\/j.jbspin.2006.06.004_bib9","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1359\/jbmr.2001.16.12.2163","article-title":"Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture","volume":"16","author":"Chesnut","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2006.06.004_bib10","series-title":"Bone Quality. What is it and can we measure it? NIH and ASBMR Meeting","year":"2005"},{"key":"10.1016\/j.jbspin.2006.06.004_bib11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S8756-3282(01)00653-6","article-title":"Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies","volume":"30","author":"Kanis","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2006.06.004_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1359\/jbmr.2002.17.1.1","article-title":"Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy","volume":"17","author":"Sarkar","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2006.06.004_bib13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"Effects of strontium ranelate on vertebral fracture risk in postmenopausal women","volume":"350","author":"Meunier","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2006.06.004_bib14","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1210\/jc.2004-1774","article-title":"Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis","volume":"90","author":"Reginster","year":"2005","journal-title":"J Clin Endrocrinol Metab"},{"key":"10.1016\/j.jbspin.2006.06.004_bib15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1385\/JCD:7:3:255","article-title":"Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate","volume":"7","author":"Watts","year":"2004","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jbspin.2006.06.004_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0002-9343(01)01124-X","article-title":"Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs","volume":"112","author":"Cummings","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.jbspin.2006.06.004_bib17","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1002\/sim.984","article-title":"A method to assess the proportion of treatment effect explained by surrogate endpoint","volume":"20","author":"Li","year":"2001","journal-title":"Stat Med"},{"key":"10.1016\/j.jbspin.2006.06.004_bib18","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1210\/jc.87.4.1586","article-title":"Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents","volume":"87","author":"Hochberg","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2006.06.004_bib19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1185\/030079903125003125","article-title":"Efficacy of risedronate on clinical vertebral fractures within six months","volume":"20","author":"Roux","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jbspin.2006.06.004_bib20","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/archinte.162.10.1140","article-title":"Early effects of raloxifene on clinical vertebral fractures at 12 months in post-menopausal women with osteoporosis","volume":"162","author":"Maricic","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jbspin.2006.06.004_bib21","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1359\/jbmr.2000.15.4.621","article-title":"True strength","volume":"15","author":"Weinstein","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2006.06.004_bib22","doi-asserted-by":"crossref","first-page":"051","DOI":"10.1359\/jbmr.2003.18.6.1051","article-title":"Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate","volume":"18","author":"Eastell","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2006.06.004_bib23","first-page":"198","article-title":"How drugs decrease fracture risk: lessons from trials","volume":"2","author":"Cummings","year":"2002","journal-title":"J\u00a0Musculoskel Neuron Interact"},{"key":"10.1016\/j.jbspin.2006.06.004_bib24","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/jc.2005-0057","article-title":"Long-term safety of bisphosphonates","volume":"90","author":"Ott","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2006.06.004_bib25","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1359\/JBMR.040512","article-title":"Changes in bone turnover and hip, non-spine and vertebral fracture in alendronate-treated women: the fracture intervention trial","volume":"19","author":"Bauer","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2006.06.004_bib26","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/s001980170020","article-title":"Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis","volume":"12","author":"Bjarnason","year":"2001","journal-title":"Osteoporosis Int"},{"key":"10.1016\/j.jbspin.2006.06.004_bib27","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2006.06.004_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1359\/jbmr.2003.18.1.9","article-title":"The effect of teriparatide [Human Parathyroid Hormone (1-34)]","volume":"18","author":"Orwoll","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2006.06.004_bib29","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1359\/jbmr.2003.18.3.539","article-title":"Sato M et\u00a0al. Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis","volume":"18","author":"Zanchetta","year":"2003","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jbspin.2006.06.004_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00198-002-1312-0","article-title":"Daily treatment with parathyroid hormone is associated with an increase in vertebral cross-sectional area in postmenopausal women with glucocorticoid-induced\u00a0osteoporosis","volume":"14","author":"Rehman","year":"2003","journal-title":"Osteoporosis Int"},{"key":"10.1016\/j.jbspin.2006.06.004_bib31","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1001\/archinte.164.18.2024","article-title":"Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis","volume":"164","author":"Lindsay","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jbspin.2006.06.004_bib32","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1210\/jc.85.6.2129","article-title":"Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate","volume":"85","author":"Rittmaster","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2006.06.004_bib33","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1359\/JBMR.050501","article-title":"Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment","volume":"20","author":"Prince","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2006.06.004_bib34","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1359\/JBMR.050312","article-title":"Intravenous bisphosphonate therapy increases radial width in adults with osteogenesis imperfecta","volume":"20","author":"Gatti","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2006.06.004_bib35","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1359\/JBMR.050508","article-title":"Effect of hormone replacement alendronate, or combination therapy on hip structural geometry: a 3-year, double-blind, placebo-controlled clinical trial","volume":"20","author":"Greenspan","year":"2005","journal-title":"J. Bone Miner Res"},{"key":"10.1016\/j.jbspin.2006.06.004_bib36","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1359\/JBMR.050326","article-title":"Relationship between bone morphology and bone quality in male tibias","volume":"20","author":"Tommasini","year":"2005","journal-title":"J Bone Miner. Res"},{"key":"10.1016\/j.jbspin.2006.06.004_bib37","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1359\/jbmr.2003.18.11.1932","article-title":"Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure","volume":"18","author":"Jiang","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"Suppl","key":"10.1016\/j.jbspin.2006.06.004_bib38","first-page":"S126","article-title":"Characterization of trabecular micro-architecture improvement under teriparatide by a fractal analysis of texture on calcaneus radiographs","volume":"1","author":"Benhamou","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2006.06.004_bib39","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/jbmr.5650091210","article-title":"Fractal organization of trabecular bone images on calcaneus radiographs","volume":"9","author":"Benhamou","year":"1994","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2006.06.004_bib40","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1359\/jbmr.2000.15.4.691","article-title":"Fractal dimension of trabecular bone projection texture is related to\u00a0three-dimensional microarchitecture","volume":"15","author":"Pothuaud","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2006.06.004_bib41","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1359\/jbmr.2002.17.7.1139","article-title":"Risedronate preserves trabecular architecture and increases bone strength in vertebra of ovariectomized minipigs as measured by 3-D computed tomography","volume":"17","author":"Borah","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2006.06.004_bib42","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00223-002-2104-4","article-title":"Risedronate preserves bone architecture in early postmenopausal women in 1 year as measured by 3-D microcomputed tomography","volume":"73","author":"Dufresne","year":"2003","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jbspin.2006.06.004_bib43","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.bone.2003.12.013","article-title":"Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by 3-D micro computed tomography","volume":"34","author":"Borah","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2006.06.004_bib44","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1185\/030079904X20259","article-title":"Trabecular bone microarchitecture after alendronate treatment of osteoporotic women","volume":"21","author":"Recker","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jbspin.2006.06.004_bib45","unstructured":"Benhamou C.L., Basillais A., Aufort G., Chappard C., Jennane R., Masarachia P., et\u00a0al. Application of a three dimensional skeleton graph analysis to patients treated by alendronate on placebo on micro-computed tomography images. NIAMS-ASBMR Scientific Meeting\u2014Bone Quality: What is it and can we measure it? May 2-3, 2005, Bethesda, MD, USA. p. 34\u201336."},{"key":"10.1016\/j.jbspin.2006.06.004_bib46","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1359\/JBMR.050411","article-title":"Effects of salmon calcitonin on trabecular microarchitecture as determined by MRI: results from the QUEST study","volume":"20","author":"Chesnut","year":"2005","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jbspin.2006.06.004_bib47","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s001980200041","article-title":"Fractal analysis of trabecular bone texture on calcaneus radiographs: effects of age, time since menopause and hormonal replacement therapy on microarchitectural changes","volume":"13","author":"Lespessailles","year":"2002","journal-title":"Osteoporosis Int"},{"key":"10.1016\/j.jbspin.2006.06.004_bib48","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00223-001-2048-0","article-title":"The degree of mineralization of bone tissue measured by computerized quantitative contact microradiography","volume":"70","author":"Boivin","year":"2000","journal-title":"Calcif Tissue Int"},{"issue":"Suppl","key":"10.1016\/j.jbspin.2006.06.004_bib49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00198-003-1469-1","article-title":"Methodological considerations in measurement of bone mineral content","volume":"5","author":"Boivin","year":"2003","journal-title":"Osteoporosis Int"},{"key":"10.1016\/j.jbspin.2006.06.004_bib50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s001980200000","article-title":"Biomechanics of bone: determinants of skeletal fragility and bone quality","volume":"13","author":"Turner","year":"2002","journal-title":"Osteoporosis Int"},{"key":"10.1016\/j.jbspin.2006.06.004_bib51","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S8756-3282(00)00376-8","article-title":"Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women","volume":"27","author":"Boivin","year":"2000","journal-title":"Bone"},{"issue":"Suppl","key":"10.1016\/j.jbspin.2006.06.004_bib52","first-page":"S261","article-title":"Effects of intravenous zoledronic acid on the degree of mineralization of bone in post-menopausal osteoporosis: a quantitative microradiographic analysis of transiliac biopsies after one year","volume":"2","author":"Boivin","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2006.06.004_bib53","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.bone.2004.12.009","article-title":"Influence of estrogen therapy at conventional and high doses on the degree of mineralization of iliac bone tissue: a quantitative microradiographic analysis in postmenopausal women","volume":"36","author":"Boivin","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2006.06.004_bib54","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1210\/jc.2002-022020","article-title":"Contribution of raloxifene and calcium and vitamin D. Supplementation to the increase of the degree of mineralization of bone in postmenopausal women","volume":"88","author":"Boivin","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2006.06.004_bib55","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1118\/1.1513161","article-title":"Quantification of the degree of mineralization of bone in three dimension using synchrotron radiation microtomography","volume":"29","author":"Nuzzo","year":"2002","journal-title":"Med Phys"},{"key":"10.1016\/j.jbspin.2006.06.004_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2005.03.017","article-title":"The effect of risedronate on bone mineralization as measured by micro-CT with synchrotron radiation: correlation to histomorphometric indices of turnover","volume":"37","author":"Borah","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2006.06.004_bib57","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1210\/jc.2002-021988","article-title":"Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment","volume":"88","author":"Misof","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2006.06.004_bib58","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s002239900371","article-title":"FTIR Microspectroscopic analysis of normal human cortical and trabecular bone","volume":"61","author":"Paschalis","year":"1997","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jbspin.2006.06.004_bib59","unstructured":"Paschalis EP, Phipps R. Long-term treatment with risedronate preserves bone quality. International Conference on Progress in Bone and Mineral Research, Vienna, November 27; 2003."},{"issue":"Suppl","key":"10.1016\/j.jbspin.2006.06.004_bib60","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1007\/s00198-003-1476-2","article-title":"Microdamage and bone strength","volume":"5","author":"Burr","year":"2003","journal-title":"Osteoporosis Int"},{"key":"10.1016\/j.jbspin.2006.06.004_bib61","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S8756-3282(00)00284-2","article-title":"Does suppression of bone turnover impair mechanical properties by allowing microdamage accumulation?","volume":"27","author":"Hirano","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2006.06.004_bib62","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.bone.2003.08.004","article-title":"Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs","volume":"33","author":"Burr","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2006.06.004_bib63","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1359\/JBMR.040126","article-title":"Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib","volume":"19","author":"Komatsubara","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2006.06.004_bib64","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S8756-3282(01)00414-8","article-title":"Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles","volume":"28","author":"Mashiba","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2006.06.004_bib65","first-page":"S22","article-title":"Risedronate and alendronate similarly suppress remodelling and increase microdamage in beagles after 1 year of treatment at clinical doses","volume":"1081","author":"Allen","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2006.06.004_bib66","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00223-002-1059-9","article-title":"Fatigue microdamage as an essential element of bone mechanics and biology","volume":"73","author":"Martin","year":"2003","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jbspin.2006.06.004_bib67","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jbspin.2006.06.004_bib68","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Durie","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2006.06.004_bib69","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jbspin.2006.06.004_bib70","unstructured":"Afssaps. Lettre aux prescripteurs. Information de pharmacovigilance. Acide zol\u00e9dronique\/pamidronate de sodium et ost\u00e9on\u00e9crose de la m\u00e2choire. 24 juin 2005."}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X06002399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X06002399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T16:54:34Z","timestamp":1555952074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X06002399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S1297319X06002399"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2006.06.004","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}